Mohammed Harb
Moncton, NB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 26, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.
Journal: Nature communications
Published: April 15, 2025
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.
Journal: Journal for immunotherapy of cancer
Published: November 11, 2024
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: December 05, 2023
Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer.
Journal: Therapeutic advances in medical oncology
Published: February 21, 2023
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma.
Journal: Nature communications
Published: May 05, 2022
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.
Journal: Current oncology (Toronto, Ont.)
Published: April 30, 2021
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer.
Journal: Clinical and translational medicine
Published: November 28, 2020
Nanowire Transistors with Bound-Charge Engineering.
Journal: Physical review letters
Published: July 10, 2020
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study.
Journal: JAMA oncology
Published: May 08, 2020
Eastern Canadian Colorectal Cancer Consensus Conference 2017.
Journal: Current oncology (Toronto, Ont.)
Published: August 17, 2018
NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.
Journal: The American journal of surgical pathology
Published: January 23, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026